Indication
Idiopathic Thrombocytopenic Purpura (ITP)
2 clinical trials
2 products
Product
ITPProduct
RomiplostimClinical trial
A Randomized, Controlled, Open-label Study Evaluating the Efficacy and Tolerability of AMG 531 Versus Medical Standard of Care as Chronic Therapy for Non-splenectomized Subjects With Immune (Idiopathic) Thrombocytopenic PurpuraStatus: Completed, Estimated PCD: 2008-11-07
Clinical trial
An Open Label Phase 2 Study Evaluating the Safety of Starting Dose of AMG 531 in Thrombocytopenic Japanese Subjects With Immune (Idiopathic) Thrombocytopenic PurpuraStatus: Completed, Estimated PCD: 2006-11-01